Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2015-03-16 Regulatory Filings
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and details a strategic decision by Genmab regarding its rights and options for a product (HuMax-TAC-ADC) in collaboration with another company (ADC Therapeutics). It announces a decision not to exercise a joint development option, retaining a 25% stake, and notes the partner's plan to file an IND application. This type of announcement, which communicates a specific, material business event or strategic update outside of routine financial reporting (like 10-K or IR), fits best under the general category of regulatory announcements or specific corporate actions. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA), and it is a formal announcement, it aligns closely with the scope of a Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the decision heavily impacted capital structure, but RNS is the broader, safer fit for non-standard corporate news releases in Danish regulatory contexts, especially when it concerns partnership terms and development rights. Given the options, RNS (Regulatory Filings / General Regulatory Announcements) is the most appropriate fallback for this specific corporate action announcement that isn't covered by a more precise code like DIV or MANG.
2015-03-16 English
Director's Dealing 2015
Director's Dealing Classification · 99% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and explicitly reports on transactions involving company shares by leading employees and their close associates ('ledende medarbejdere og disses nærtståendes transaktioner med Genmab aktier'). It details the name, role, transaction type (Salg/Sale), date, and volume/value for multiple directors. This content directly corresponds to the definition of Director's Dealing reports, which track personal share transactions by company directors and executives (insider trades). The appropriate code is DIRS.
2015-03-12 Danish
Director's Dealing 2015
Director's Dealing Classification · 99% confidence The document is explicitly titled "Report Pursuant to Section 28a of the Danish Securities Trading Act" and details transactions involving shares by managerial employees (Board of Directors members) and their related parties. This content directly corresponds to the definition of insider trading reports or director's dealings. The filing category 'Directors Dealing (DIRS)' is the most appropriate fit for reporting personal share transactions by company directors and executives.
2015-03-12 English
Director's Dealing 2015
Director's Dealing Classification · 99% confidence The document is explicitly titled 'Report Pursuant to Section 28a of the Danish Securities Trading Act' and details transactions involving shares by managerial employees and members of the Board of Directors (e.g., Name: Anders Gersel Pedersen, Reason: Member of the Board of Directors). This content directly corresponds to insider trading disclosures or director's dealings reports. Comparing this to the provided definitions, 'Director's Dealing (Code: DIRS)' is the most accurate classification, as it covers 'Report of personal share transactions by company directors and executives (insider trades)'. The document is the report itself, not an announcement of a report.
2015-03-11 English
Director's Dealing 2015
Director's Dealing Classification · 100% confidence The document is titled "Company Announcement" and explicitly states that it is made pursuant to Danish securities law to publicize transactions by managerial employees and related parties involving company shares. It details the Name, Reason (Member of the Board of Directors), Transaction (Purchase), Trading date, Number, and Value for two individuals. This content directly corresponds to the definition of Director's Dealing reports, which track insider transactions.
2015-03-11 English
Share Issue/Capital Change 2015
Share Issue/Capital Change Classification · 98% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and dated March 11, 2015. The core content details an increase in share capital (aktiekapital) resulting from the exercise of employee warrants, specifying the number of shares and the cash proceeds. It also mentions the impact on the company's liquidity outlook and notes that board members exercised warrants. This type of announcement, concerning the issuance of new shares due to warrant/option exercise and the resulting capital structure change, directly aligns with the definition of a Share Issue/Capital Change (SHA). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific capital event.
2015-03-11 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.